PMV Pharmaceuticals (PMVP) EV/EBIT: History & Chart

PMV Pharmaceuticals, Inc.(PMVP)

Biotechnology · Princeton, NJ

$1.68-0.10 (-5.90%)

Delayed quote: Oct 6, 2026, 2:45 PM EDT

About PMV Pharmaceuticals, Inc.

PMV Pharmaceuticals, Inc. operates as a precision oncology company focused on discovering and developing both small molecule and tumor-agnostic therapies to address p53 mutations in cancer patients. Their leading experimental drug, PC14586, is a small molecule designed to correct the p53 protein specifically when it contains the Y220C mutation, thereby restoring its natural, functional state. The company is also progressing a pipeline of other programs targeting various mutant p53 forms, including Wild-type p53 Induced-Phosphatase, R282W, R273H, and other prevalent p53 hotspot mutations. Originally known as PJ Pharmaceuticals, Inc., the firm rebranded to PMV Pharmaceuticals, Inc. in July 2013. The company was founded in 2013 and has its main operational base in Cranbury, New Jersey.

Princeton, NJ

54 employees

www.pmvpharma.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: David H. Mack

View full financials

NAME	MARKET CAP	EV/EBIT RATIO	TTM	3Y	5Y
PMV Pharmaceuticals, Inc. (PMVP)	$89.33M	N/A	N/A	N/A	N/A
CareCloud, Inc. (CCLD)vs ›	$88.81M	13.77x	11.03x	8.69x	166.50x
electroCore, Inc. (ECOR)vs ›	$89.89M	N/A	N/A	N/A	N/A
Rallybio Corporation (RLYB)vs ›	$90.72M	N/A	N/A	N/A	N/A
Neumora Therapeutics, Inc. Common Stock (NMRA)vs ›	$88.38M	N/A	N/A	N/A	N/A
ImmuCell Corporation (ICCC)vs ›	$90.20M	24.26x	34.08x	34.41x	73.74x
Biomea Fusion, Inc. (BMEA)vs ›	$91.10M	N/A	N/A	N/A	N/A
Equillium, Inc. (EQ)vs ›	$90.73M	N/A	N/A	N/A	N/A
Conexeu Sciences Inc. (CNXU)vs ›	$91.65M	N/A	N/A	N/A	N/A
Park Dental Partners, Inc. Common Stock (PARK)vs ›	$92.47M	N/A	N/A	N/A	N/A

NAME

MARKET CAP

EV/EBIT RATIO

TTM

PMV Pharmaceuticals, Inc. (PMVP)

$89.33M

N/A

CareCloud, Inc. (CCLD)vs ›

$88.81M

13.77x

11.03x

8.69x